Form 4: ClearPoint Neuro Director Acquires Shares as Compensation
Insider Transaction Report
ClearPoint Neuro, Inc. Director Timothy T. Richards acquired 934 shares of common stock on July 1, 2025, as part of his non-employee director compensation.
Summary
- Timothy T. Richards, a Director of ClearPoint Neuro, Inc. (CLPT), acquired 934 shares of common stock.
- The transaction occurred on July 1, 2025.
- The shares were acquired at a price of $11.94 per share.
- These shares were issued as payment for fees owed to Mr. Richards under the company's Non-Employee Director Compensation Plan, as amended and restated.
- The issuance was made pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan.
- Following this transaction, Mr. Richards directly beneficially owns 78,315 shares of ClearPoint Neuro common stock.
Sentiment
Score: 7
Explanation: The acquisition of shares by a director, even as compensation, generally indicates alignment of interests with shareholders and confidence in the company's equity value.
Positives
- Director Timothy T. Richards increased his direct beneficial ownership in ClearPoint Neuro, Inc. by acquiring 934 shares, aligning his interests further with shareholders.
- The issuance of shares as compensation demonstrates the company's commitment to its established incentive compensation plan for non-employee directors.
Future Outlook
NA
Management Comments
- Shares were issued pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated.
Industry Context
This Form 4 filing reflects an internal compensation event for ClearPoint Neuro, Inc., and does not directly relate to broader industry trends or competitor activities. It is a standard disclosure for insider transactions.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Plan Execution | The transaction was executed under the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan and the Non-Employee Director Compensation Plan, indicating adherence to established corporate governance frameworks for director compensation. | 07/01/2025 | Reinforces the existing compensation structure for non-employee directors and aligns their interests with company performance. |
Related Party Transactions
- The acquisition of shares by Director Timothy T. Richards as payment for fees under the Non-Employee Director Compensation Plan constitutes a related party transaction, as it involves a key management personnel and the company.
Stakeholder Impact
- Shareholders: The increase in director ownership may be viewed positively, signaling confidence and aligning director interests with shareholder value.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date used to determine the closing price of the issuer's common stock for share issuance. |
| 07/01/2025 | Date of the transaction where shares were acquired by Timothy T. Richards. |
| 07/02/2025 | Date the Form 4 was signed by Power of Attorney for Timothy T. Richards. |
Recommendation
holdKeywords
ClearPoint Neuro, CLPT, Form 4, insider transaction, director compensation, stock acquisition, equity, common stock, incentive plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.